Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportTechnologist Student Abstract Track

Radiochemical purity and stability of generic Tc-99m Exametazime compared to Tc-99m Ceretec

Forest Hynes, Mike Zimmer, Bruce Voll, Lisa Riehle and Stewart Spies
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 2727;
Forest Hynes
1Nuclear Medicine, Northwestern Memorial Hospital, Chicago, IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Zimmer
1Nuclear Medicine, Northwestern Memorial Hospital, Chicago, IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Voll
1Nuclear Medicine, Northwestern Memorial Hospital, Chicago, IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Riehle
1Nuclear Medicine, Northwestern Memorial Hospital, Chicago, IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stewart Spies
1Nuclear Medicine, Northwestern Memorial Hospital, Chicago, IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

2727

Objectives Tc-99m Ceretec (GE Healthcare) is used to evaluate cerebral blood flow. Recently a generic version of Tc-99m exametazime has been introduced. The objective of this study was to evaluate the radiochemical purity and stability of generic Tc-99m exametazime (AnazaoHealth) and compare the results to Tc-99m Ceretec.

Methods Both radiopharmaceutical kits were evaluated at low (50 mCi) and high activity (80 mCi). Kits were formulated according to manufacturers instructions. For each specific preparation, the radiochemical purity and stability was evaluated up to 7 or 8 hours after formulation using miniaturized chromatography consisting of Whatman 17 with ethyl acetate. For each specific chromatographic evaluation, three replicate samples were analyzed. Data was summarized by calculating mean percent radiochemical purity.

Results At low activity, the initial radiochemical purity of generic Tc-99m exametazime and Tc-99m Ceretec was 87% and 95%, respectively. The radiochemical purity of generic Tc-99m exametazime remained greater than 80% up to 6 hours after formulation. At 7 hours after formulation the radiochemical purity of generic Tc-99m exametazime was 78%, indicating preparation failure. The radiochemical purity of Tc-99m Ceretec remained greater than 80% up to 7 hours after formulation. At high activity, the initial radiochemical purity of generic Tc-99m exametazime and Tc-99m Ceretec was 85% and 95%, respectively. For both formulations the radiochemical purity remained greater than 80% up to 6 hours. At 7 hours post formulation, the radiochemical purity of generic Tc-99m exametazime and Tc-99m Ceretec were 78% and 79%, respectively, indicating preparation failure.

Conclusions The radiochemical purity and stability of generic Tc-99m exametazime and Tc-99m Ceretec was greater than 80% up to 6 hours post formulation at both low and high activity. At 7 hours post formulation, only the low activity Tc-99m Ceretec preparation maintained a labeling efficiency greater than 80%

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiochemical purity and stability of generic Tc-99m Exametazime compared to Tc-99m Ceretec
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiochemical purity and stability of generic Tc-99m Exametazime compared to Tc-99m Ceretec
Forest Hynes, Mike Zimmer, Bruce Voll, Lisa Riehle, Stewart Spies
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 2727;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiochemical purity and stability of generic Tc-99m Exametazime compared to Tc-99m Ceretec
Forest Hynes, Mike Zimmer, Bruce Voll, Lisa Riehle, Stewart Spies
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 2727;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Technologist Student Abstract Track

  • A comparison in the percent remaining of a gastric empty study that is acquired anterior only versus anterior and posterior.
  • Implementing a modified Russell two-point method to measure glomerular filtration rates (GFR).
  • Yttrium-90 radioembolization and the prolonged life expectancy of colorectal cancer patients.
Show more Technologist Student Abstract Track

Technologist Student Scientific Papers III

  • Critical deficiencies of radiopharmaceutical reconstitution and quality control instructions.
  • Wipe counting efficiency of Radium 223 Chloride using a specific counting methodology.
  • Implementing a modified Russell two-point method to measure glomerular filtration rates (GFR).
Show more Technologist Student Scientific Papers III

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire